Heart Failure With Preserved Ejection Fraction in Low‐Income Settings: Performance and Challenges of Screening Scores in a Population‐Based Cohort in Haiti
Journal of the American Heart Association · 18.11.2026
DOI: 10.1161/jaha.126.049654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, online erschienen am 18.11.2026. Verfasst von Lily D. Yan und 19 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Heart failure with preserved ejection fraction (HFpEF) is rapidly increasing in low‐ and middle‐income countries, however detection remains challenging. We assessed 2 screening scores developed in high‐income settings, H2FPEF and HFA‐PEFF, against physician‐adjudicated HFpEF in a population‐based cohort from Haiti.
Methods
The primary outcome was prevalent HFpEF defined by (1) physician adjudication, (2) H2FpEF score, (3) HFA‐PEFF score. The cross‐sectional cohort comprised 3003 adults from the Haiti Cardiovascular Disease Cohort, with sociodemographic, clinical, electrocardiography, echocardiography and BNP data available. We compared physician‐adjudicated HFpEF participants to those screening positive (intermediate‐high H2FPEF and HFA‐PEFF scores) using interrater reliability (Cohen's kappa, Krippendorff's alpha). Diagnostic performance of H2FPEF and HFA‐PEFF against physician adjudication, used as a pragmatic reference standard appropriate for Haiti and similar settings, was calculated via sensitivity, specificity, and predictive values.
Results
Age‐adjusted HFpEF prevalence was 9.5% (95% CI: 8.3–11.0) by physician adjudication, 10.2% (95% CI: 9.0–11.7) by H2FPEF, and 8.6% (95% CI: 7.5–10.0) by HFA‐PEFF. Adjudicated HFpEF participants were young (median age 57), had high prevalence of hypertension (70%), obesity (33%), and no atrial fibrillation. Agreement between all 3 scores was moderate‐substantial (alpha 0.57, 95% CI: 0.55–0.59), with the highest pair‐wise agreement between physician adjudication and HFA‐PEFF (kappa 0.62, 95% CI: 0.57–0.67). HFA‐PEFF had higher sensitivity and similar specificity relative to H2FPEF.
Conclusions
In this Haitian cohort, prevalent HFpEF occurred in relatively young participants with high hypertension and obesity rates and negligible atrial fibrillation. HFA‐PEFF exhibited higher concordance and sensitivity than H2FPEF versus physician adjudication. Tailored, non‐invasive HFpEF screening scores for low‐ and middle‐income countries are needed to address this growing global epidemic.
Zitieren
APA
Yan, L. D., Sauveur, R. S., Celestin, K., Macajou, K. J. W., Ogyu, A., Rouzier, V., Apollon, A., Marx, D., Bennett, C., Alexandre, W., Malebranche, R., Théard, M., Brisma, J. P., Ward, M., Dupnik, K., Kwan, G. F., Deschamps, M. M., Pape, J. W., Dávila‐Román, V. G., & McNairy, M. L. (2026). Heart Failure With Preserved Ejection Fraction in Low‐Income Settings: Performance and Challenges of Screening Scores in a Population‐Based Cohort in Haiti. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.049654
Vancouver
Yan LD, Sauveur RS, Celestin K, Macajou KJW, Ogyu A, Rouzier V, et al. Heart Failure With Preserved Ejection Fraction in Low‐Income Settings: Performance and Challenges of Screening Scores in a Population‐Based Cohort in Haiti. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.049654
BibTeX
@article{Yan2026,
author = {Yan, Lily D. and Sauveur, Reichling St. and Celestin, Kelly and Macajou, Kevin Jerry Williams and Ogyu, Anju and Rouzier, Vanessa and Apollon, Alexandra and Marx, Darby and Bennett, Catherine and Alexandre, Wheytnie and Malebranche, Rodolphe and Théard, Michel and Brisma, Jean Pierre and Ward, Maureen and Dupnik, Kathryn and Kwan, Gene F. and Deschamps, Marie Marcelle and Pape, Jean W. and Dávila‐Román, Victor G. and McNairy, Margaret L.},
title = {Heart Failure With Preserved Ejection Fraction in Low‐Income Settings: Performance and Challenges of Screening Scores in a Population‐Based Cohort in Haiti},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.126.049654}
}
EUVIMED